Daré Bioscience DARE-HPV program advances with non-dilutive US government funding
DARE•DARE-HPV program advances with government funding
- Daré Bioscience said its DARE-HPV program for persistent high-risk HPV is advancing with non-dilutive government funding.
- The company did not disclose the funding amount or the agency.
